CHASTITY BENSON: Open Payments
NPI 1053947150 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 31 payments from 15 companies in 2025. Trend: 2023 $52 · 2024 $245 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $170 |
| Janssen Pharmaceuticals, Inc | 2 | $143 |
| ABBVIE INC. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| SHIELD THERAPEUTICS INC | 1 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $26 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: INVEGA SUSTENNA, Ozempic, CAPLYTA, VRAYLAR, ACCRUFER, UZEDY, VERQUVO, LifeVest.
Industry payments across NC — which companies pay providers there.
